Oncology

Latest News

COVID-19 vaccine for patients with cancer. | Image Credit: Framestock - stock.adobe.com

COVID-19 Boosters Crucial for Patients With Cancer Despite Low Uptake

July 17th 2025

Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.

AJMC Q&A with Robert Kratzke | Background image credit: ipopba - stock.adobe.com

Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD

By Hayden E. Klein
Robert Kratzke, MD

July 15th 2025

The investigators found that patients with SCLC and cachexia were more likely to have problems with treatment. | Image credit: appledesign - stock.adobe.com

Cachexia Worsens Prognosis in Older Patients With Advanced SCLC

By Jared Kaltwasser

July 9th 2025

Insurance gaps | Image Credit: iQoncept-stock.adobe.com

Insurance Gaps Threaten Cancer Treatment Success

By Maggie L. Shaw

July 7th 2025

Analyzed by birth cohort, the authors found each successive birth cohort had a 7.7% decline in SCLC rates. | Image credit: shidlovski

Decline in SCLC Incidence Expected to Accelerate Through 2050

By Jared Kaltwasser

June 29th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

Continuing Medical Education

View All

July 17th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

July 17th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

February 26th 2013

From Bench to Bedside: Promising Colon Cancer Clinical Trials

Jill M. Comeau, PharmD, BCOP Brice Labruzzo Mohundro, PharmD, BCACP

February 26th 2013

The Future of Oncology? COME HOME, the Oncology Medical Home

Barbara L. McAneny, MD

February 26th 2013

Focusing on Clinical and Economic Outcomes-Not Guidelines

Is It Time for a New Direction in Oncology Care?

Interview With Andrew Pecora, MD, CPE, President, Regional Cancer Care Associates, Chief Innovations Officer and Vice President, Cancer Services, John Theurer Cancer Center at Hackensack University Medical Center

February 26th 2013

The Role of Companion Diagnostic Testing in Payer Decision Making

Jerry Conway

February 26th 2013

Literature Review: Chronic Myeloid Leukemia

February 25th 2013

Lessons From an Oncology Medical Home Collaborative

John Fox, MD, MHA

February 22nd 2013

FDA Approves New Treatment for Late-Stage Breast Cancer

February 19th 2013

Cancer Rehab Begins To Bridge A Gap For Patients

February 18th 2013

The Growing Cost of Specialty Pharmacy-Is it Sustainable?

We only have to take a brief look back to see that 10 years ago, most specialty drugs were injectable agents used to treat conditions such as rheumatoid arthritis, multiple sclerosis, and growth disorders. Today, the list of agents that is considered specialty includes many oral drugs and even some inhaled agents. In just more than 2 decades, the specialty drug market place has grown substantially.

February 13th 2013

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

Suja S. Rajan, MHA, MS, PhD William R. Carpenter, MHA, PhD Sally C. Stearns, PhD Gary H. Lyman, MD, MPH

Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.

January 30th 2013

Abraxane Capitalizes on the Resurgence of Chemotherapy Combinations in Pancreatic Cancer at ASCO GI 2013

January 29th 2013

Less is More? New Study Indicates Less Invasive Treatment May Yield Better Results for Breast Cancer Patients

January 24th 2013

Bruce Feinberg, DO, Speaks About Clinical Pathways in Oncology Care

Bruce Feinberg, DO, Vice President and Chief Medical Officer, Cardinal Health Specialty Solutions, says that there is a tremendous amount of waste in the system.

January 22nd 2013

Darius Lakdawalla, PhD, Discusses the Payer/Provider Relationship in Oncology Management

Darius Lakdawalla, PhD, Director of Research, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, thinks that payers follow the lead of providers in oncology management.

January 21st 2013

Revisiting the Integrated Delivery Network Model

The idea behind an integrated delivery network (IDN)-a concept that was developed in the 1980s and widely implemented in the 1990s-is that a network of facilities and providers can work together to offer a continuum of care in a particular geographic area. Although the concept was one that initially drew praise, the implementation of this type of system did not gain momentum from the onset. However, as time has elapsed, advancements have made this model worth revisiting.

January 21st 2013

New Pump a 'Game-Changer' for Cancer Patients

January 16th 2013

500,000 Women to be Offered Breast Cancer Drugs

January 15th 2013

Jan Berger, MD, MJ, Addresses Challenges in Oncology Management

"Oncology is a very emotional area," says Jan Berger, MD, MJ, President & CEO, Health Intelligence Partners, Editor-in-Chief, The American Journal of Pharmacy Benefits.

January 10th 2013

Pap Test For Ovarian Cancer, Coming Soon?

January 2nd 2013

Robert Gamble Talks about the Challenges Payers and Providers Face in Oncology Management

In this video, Robert Bo Gamble, Director, Strategic Practice Initiatives, Community Oncology Alliance, Washington, DC, says that it is critical for payers and providers to come together in oncology management.

January 2nd 2013

Expert Roundtable Panel Discussion: The Future of Payer Management of Oncology

December 31st 2012

Introduction

December 31st 2012

Oncology, Innovation, and Healthcare

This article is based on the keynote address by Clifford Goodman, PhD

December 31st 2012

Developing Comparative Effectiveness Research in Oncology

This article is based on the presentation by Jeffrey D. Dunn, PharmD, MBA

December 31st 2012

Practical Application of Clinical Pathways

This article is based on the presentation by Bruce A. Feinberg, DO

December 31st 2012

Quality Measures in Oncology

This article is based on the presentation by Ira M. Klein, MD, MBA, FACP

December 31st 2012

Innovative Payment Models in Oncology Care

This article is based on the presentation by Peter B. Bach, MD, MAPP

December 31st 2012

Data Tracking and Point of Service Decision Support

This article is based on the presentation by Andrew L. Pecora, MD, FACP, CPE

December 31st 2012

Healthcare, the National Debt, and Taxes

This article is based on the presentation by Michael E. Chernew, PhD

December 9th 2012

Richard T. Hoppe, MD, Discusses the Current Role and Utility of Radiation Therapy

Richard T. Hoppe, MD, Professor of Radiation Oncology - Radiation Therapy, Stanford School of Medicine, discussed the current role and utility of radiation therapy in patients with early stage Hodgkins Lymphoma when compared to conventional chemotherapy.

...

175 176 177 178 179 180 181 182 183

...

186 >